Soriot should explain the curious case of AstraZeneca’s non-deal

AstraZeneca’s rumoured takeover of Bristol Myers Squibb already looked weird, and was met with a lack of enthusiasm by shareholders AstraZeneca falls to third-largest UK company amid US merger talks Hold the heartburn pills. It seems AstraZeneca is no longer contemplating a…